financetom
Business
financetom
/
Business
/
Ridgemar's owner explores $1 billion-plus sale of US oil producer, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ridgemar's owner explores $1 billion-plus sale of US oil producer, sources say
Nov 13, 2024 1:42 PM

NEW YORK, Nov 13 (Reuters) - The private equity owner of

Ridgemar Energy is exploring a sale of the U.S. oil and gas

producer that could value the company at more than $1 billion,

including debt, people familiar with the matter told Reuters on

Wednesday.

Ridgemar, which is backed by Carnelian Energy Capital, is

working with investment bankers at RBC Capital Markets on a sale

process for its operations in the Eagle Ford Basin of South

Texas, the sources said, requesting anonymity as the discussions

are confidential.

Potential buyers include publicly listed and privately owned

energy producers, the sources added, cautioning that a deal is

not guaranteed.

Carnelian, Ridgemar and RBC did not respond to requests for

comment.

Private equity firms have been active sellers of energy

assets in recent years, as higher commodity prices have helped

them exit oil and gas investments profitably.

Earlier this year, energy-focused private equity firm EnCap

Investments sold XCL Resources and Grayson Mill Energy to SM

Energy ( SM ) and Devon Energy ( DVN ) respectively. In July,

Point Energy Partners, which is backed by Vortus Investments,

sold its assets to Vital Energy ( VTLE ) and Northern Oil and

Gas ( NOG ).

Houston, Texas-based Ridgemar is one of the top remaining

private oil producers in the Eagle Ford. In 2023, Ridgemar

acquired the Eagle Ford assets of Callon Petroleum for $655

million in cash and $45 million in potential contingent

payments.

The company has since expanded its operations through

smaller deals, adding about 17,000 net acres to boost its total

holdings to more than 70,000 net acres in the western portion of

the Eagle Ford, the sources said.

Ridgemar expects in 2025 production to average around 27,000

barrels of oil equivalent per day, with core earnings of more

than $450 million, the sources added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Magnite Insider Sold Shares Worth $298,399, According to a Recent SEC Filing
Magnite Insider Sold Shares Worth $298,399, According to a Recent SEC Filing
Jun 14, 2024
04:36 PM EDT, 06/14/2024 (MT Newswires) -- David Day, CFO, on June 12, 2024, sold 21,299 shares in Magnite ( MGNI ) for $298,399. Following the Form 4 filing with the SEC, Day has control over a total of 449,832 shares of the company, with 449,832 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1595974/000141588924016936/xslF345X03/form4-06142024_040626.xml Price: 13.48, Change: -0.25, Percent Change: -1.82 ...
Canada in contact with foreign regulators on probe of titanium in Boeing, Airbus jets
Canada in contact with foreign regulators on probe of titanium in Boeing, Airbus jets
Jun 14, 2024
MONTREAL, June 14 (Reuters) - Canada's transportation regulator said on Friday it was in contact with foreign regulators for a coordinated approach to allegations that Boeing ( BA ) and Airbus were sold titanium components with fake documentation. Transport Canada, in an emailed statement, said it was also working with Canadian manufacturers to ensure proper management of any safety implications...
United Therapeutics Insider Sold Shares Worth $1,027,716, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,027,716, According to a Recent SEC Filing
Jun 14, 2024
04:37 PM EDT, 06/14/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on June 13, 2024, sold 3,600 shares in United Therapeutics ( UTHR ) for $1,027,716. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 647,195 shares of the company, with 130 shares held directly and 647,065 controlled indirectly. SEC Filing:...
AbbVie Says Investors Should Sit Out Tutanota Mini-Tender Offer
AbbVie Says Investors Should Sit Out Tutanota Mini-Tender Offer
Jun 14, 2024
04:37 PM EDT, 06/14/2024 (MT Newswires) -- AbbVie ( ABBV ) late Friday recommended shareholders decline from participating in an unsolicited mini-tender offer from Tutanota seeking to buy up to 250,000 of the drug maker's shares at $165 apiece. AbbVie ( ABBV ) said the May 28 tender offer is conditioned on its share price closing above the offer price...
Copyright 2023-2025 - www.financetom.com All Rights Reserved